Preparation method of carbon dot nano-enzyme combined with natural enzyme to strengthen hypoxic tumor photodynamic therapy

By preparing platinum@toluidine blue carbon dot nanoenzyme and folic acid coating, the problems of low 1O2 yield and hypoxic environment limitation in the prior art were solved, efficient tumor photodynamic treatment was achieved, and therapeutic effect and biological treatment were enhanced. Compatibility.

CN118976118APending Publication Date: 2024-11-19ZHEJIANG SCI-TECH UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410935597.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing carbon dot nanoenzymes have a low yield of 1O2 in tumor photodynamic therapy, requiring large doses to achieve therapeutic effect, and the hypoxic environment limits the therapeutic effect.

Method used

Platinum@toluidine blue carbon dot nanoenzyme was prepared by hydrothermal method, and the coordination effect of thiol-polyethylene glycol-glucose oxidase and platinum group was connected, and finally coated with folic acid to form a good biocompatible and single-line Tumor photodynamic therapy materials with high state oxygen yields can achieve three-collaborative treatments for starvation/chemical dynamics/photodynamics.

Benefits of technology

It significantly improves singlet oxygen yield, enhances anti-tumor effect, improves the biocompatibility and targeting of the therapeutic materials, and reduces damage to normal cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004941229760000111
    Figure BDA0004941229760000111
  • Figure BDA0004941229760000112
    Figure BDA0004941229760000112
  • Figure BDA0004941229760000121
    Figure BDA0004941229760000121
Patent Text Reader

Abstract

The invention relates to the field of biomedical materials, and discloses a preparation method of a carbon dot nano-enzyme combined with a natural enzyme to strengthen hypoxic tumor photodynamic therapy. The preparation method comprises the following steps: firstly, preparing platinum-toluidine blue carbon dot nano-enzyme by utilizing a hydrothermal method, then synthesizing sulfydryl-polyethylene glycol-glucose oxidase by utilizing sulfydryl-polyethylene glycol-amino and glucose oxidase, and then connecting the sulfydryl-polyethylene glycol-glucose oxidase through a coordination effect of sulfydryl and platinum. And finally, coating the platinum-coated toluidine blue-polyethylene glycol-glucose oxidase carbon dot nano-enzyme with folic acid to finally obtain the tumor photodynamic therapy material with good biocompatibility and high singlet oxygen yield. The nano composite material has multiple functions, can realize hunger / chemical power / photodynamic three-synergistic treatment, realizes high singlet oxygen yield in a tumor microenvironment through cascade reaction effects of glucose oxidase and platinum-coated toluidine blue carbon dot nano enzyme, can enhance the anti-tumor effect, and is expected to be actually applied to tumor treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedical materials, and more specifically relates to a method for preparing a carbon dot nanozyme for strengthening photodynamic therapy of hypoxic tumors in combination with natural enzymes. Background Art

[0002] In recent years, the development of nanomaterials has accelerated, and significant progress has been made in tumor diagnosis and treatment. Nanozymes have the functions of enzymes and the characteristics of nanomaterials, showing great potential. So far, various nanozymes have been developed, including metal nanoparticles, metal oxide nanoparticles, carbon-based nanomaterials and metal-organic framework materials, which have important research value and significance in biomedical applications.

[0003] Carbon dot (CD) nanozymes have many advantages, including small particle size and biocompatibility, and can be quickly excreted through the kidneys. In addition, CDs also have multiple types of enzyme activities, such as peroxidase (POD) and oxidase activities, generating reactive oxygen species (ROS) to inhibit tumor growth.

[0004] In tumor photodynamic therapy (PDT), an ideal photosensitizer must usually have high singlet oxygen ( 1 O2) yield, low toxicity and excellent photostability. Various precursors of carbon dots, including chemical reagents (such as phenylenediamine, 4-vinylphenylboronic acid) and natural biomass (such as spinach, crab shells) have been widely studied, but the results are not satisfactory. Toluidine blue (TB) is a safe and effective photosensitizer. Its potential in tumor photodynamic therapy has been confirmed in a variety of somatic tumors and has antibacterial properties. However, the 1 O2 production is low and requires large doses to achieve a certain therapeutic effect, so exploring ways to increase its 1 The method of O2 yield has positive significance. Summary of the invention

[0005] In order to solve the above technical problems, the present invention provides a method for preparing a carbon dot nanozyme for strengthening the photodynamic therapy of hypoxic tumors by combining natural enzymes. The present invention first prepares platinum @ toluidine blue carbon dot nanozyme by hydrothermal method, and then synthesizes thiol-polyethylene glycol-glucose oxidase by thiol-polyethylene glycol-amino and glucose oxidase, and then connects it through the coordination effect of thiol and platinum, and finally coats platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme with folic acid, and finally obtains a tumor photodynamic therapy material with good biocompatibility and high singlet oxygen yield. The nanocomposite material obtained by the method can realize the three synergistic treatments of starvation / chemodynamics / photodynamics by having multifunctionality, and realizes the high singlet oxygen yield in the tumor microenvironment through the cascade reaction effect of glucose oxidase and platinum @ toluidine blue carbon dot nanozyme, which can enhance its anti-tumor effect and is expected to be actually used in tumor treatment.

[0006] In order to achieve the above object, the present invention is implemented by the following technical scheme: a method for preparing carbon dot nanozymes for strengthening hypoxic tumor photodynamic therapy by combining natural enzymes, comprising the following steps:

[0007] Step 1: Platinum @ toluidine blue carbon dot nanozyme: Add 1.0-1.2g citric acid, 0.3-0.4mL ethylenediamine, 0.06-0.08g toluidine blue and 0.5-0.6g chloroplatinic acid hexahydrate to 20-30mL water under stirring, and the resulting solution is hydrothermally reacted at 160-180℃ for 10-12h, cooled, filtered, and the filtrate is dialyzed for purification, centrifuged and washed, and freeze-dried to obtain platinum @ toluidine blue carbon dot nanozyme.

[0008] The present invention finds that the amount of citric acid and ethylenediamine added has a great influence on the above reaction. As the amount of citric acid and ethylenediamine added gradually increases, the quantum yield of the obtained carbon dots will increase. However, when the amount of ethylenediamine added exceeds 0.4 mL, the carbonization effect of toluidine blue will decrease significantly.

[0009] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: Dissolve 20-40 mg of thiol-polyethylene glycol-amino in 10-20 mL of 2-morpholineethanesulfonic acid buffer, add 50-100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 30-60 mg of N-hydroxysuccinimide, stir to dissolve, transfer to a shaker for incubation and activation, add 10-20 mL of glucose oxidase solution after the end, adjust the pH to 6.5-7.0, incubate on a shaker overnight, collect the precipitate by centrifugation, and dilute with water to obtain a 1-2 mg / mL thiol-polyethylene glycol-glucose oxidase solution.

[0010] 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide are used to promote the amidation reaction. The inventors found that when the amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride added is less than 50 mg, the carboxyl group cannot be fully activated and the amidation reaction efficiency is significantly reduced; when the amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride added exceeds 100 mg, a self-polymerization reaction occurs, resulting in agglomeration in the obtained thiol-polyethylene glycol-glucose oxidase solution.

[0011] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 80-100 mg of platinum@toluidine blue carbon dot nanozyme in 40-50 mL of phosphate buffered saline, add 10-20 mL of thiol-polyethylene glycol-glucose oxidase solution, stir and mix to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution.

[0012] The thiol group and the platinum group form a coordination bond through the lone pair of electrons of the sulfur atom and the unfilled electrons on the d orbital of platinum to form a platinum-thiol complex. When the thiol-polyethylene glycol-glucose oxidase solution is excessive, the excess thiol group will further combine with the platinum atom in the formed platinum-thiol complex, resulting in supersaturation of the coordination bond, reducing the stability of the complex, causing it to dissociate or decompose, and at the same time, the excess thiol group will also occupy the active site of the platinum atom, hindering the effective contact and reaction between the substrate and the platinum atom.

[0013] Step: 4: Preparation of platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: dissolve 20-30 mg of folic acid in 20-30 mL of borate buffer to prepare a folic acid solution, add 10-20 mL of an aqueous solution containing 10-20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 6-12 mg of N-hydroxysuccinimide, stir to dissolve, transfer to a shaker for incubation and activation, and then add 20-30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, incubate on a shaker overnight, dialysis purification, centrifugal ultrafiltration concentration, and obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0014] By combining platinum@toluidine blue-polyethylene glycol-glucose oxidase with folic acid, targeted therapy can be achieved for tumor cells with high expression of folate receptors. The dosage ratio of folic acid to platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution is controlled within the range of 20-30mg:20-30mL. Excessive folic acid will interfere with the normal function of platinum@toluidine blue-polyethylene glycol-glucose oxidase, resulting in decreased chemodynamic and photodynamic therapy effects, and will also increase the toxicity of the material, leading to increased biological rejection of the material.

[0015] In summary, in the above steps, the present invention first uses a hydrothermal method to prepare platinum @ toluidine blue carbon dot nanozyme, then uses thiol-polyethylene glycol-amino and glucose oxidase to synthesize thiol-polyethylene glycol-glucose oxidase, and then connects it through the coordination effect of the thiol group and the platinum group, and finally coats the platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme with folic acid, and finally obtains a tumor photodynamic therapy material with good biocompatibility and high singlet oxygen yield. The nanocomposite material obtained by this method can achieve starvation / chemodynamic / photodynamic triple synergistic therapy through multifunctionality, and achieves a high singlet oxygen yield in the tumor microenvironment through the cascade reaction effect of glucose oxidase and platinum @ toluidine blue carbon dot nanozyme, which can enhance its anti-tumor effect and is expected to be actually used in tumor treatment. Specifically:

[0016] In the present invention, platinum nanoparticles can generate oxygen by catalyzing hydrogen peroxide in the tumor microenvironment, which can enhance the mobility and tumor penetration of platinum nanoparticles, thereby enhancing their therapeutic effect. In addition, platinum nanoparticles themselves also have a chemotherapeutic effect and can kill tumor cells by leaching platinum ions.

[0017] Toluidine blue is a safe and effective photosensitizer. Its potential in tumor photodynamic therapy has been demonstrated in a variety of somatic tumors and has antibacterial properties. 1 The O2 production rate is low, and a large dose is required to achieve a certain therapeutic effect. The present invention finds that doping toluidine blue with platinum can significantly increase its singlet oxygen production rate; at the same time, platinum can also overcome hypoxia by decomposing H2O2 in the tumor microenvironment into O2, thereby improving the photodynamic therapy effect of tumors that rely on O2.

[0018] Glucose oxidase catalyzes the degradation of glucose in tumors to produce H2O2, which can not only achieve starvation therapy by consuming tumor nutrients, but also the produced H2O2 can be used for subsequent Fenton-like reactions to enhance the effect of tumor photodynamic therapy in the hypoxic microenvironment of tumors. On this basis, the present invention synthesizes thiol-polyethylene glycol-glucose oxidase, which can be combined through the coordination effect of thiol and platinum groups, further optimizing the biological properties of carbon dot nanozymes, so that the material has extremely excellent biocompatibility.

[0019] Due to the high affinity of folic acid to cell surface folate receptors, folate receptors are highly expressed on the surface of most tumor cells, but not expressed or very rarely expressed on the surface of normal cells. The present invention modifies the carbon dot nanozymes with folic acid, mediates the endocytosis of folate receptors, and delivers them to cancer cells, which can exert a therapeutic effect equivalent to or higher than that of the parent drug. In this way, the damage of carbon dot nanozymes to normal cells and tissues will be greatly reduced, and the targeting of carbon dot nanozymes will also be improved.

[0020] Preferably, in step 1: the filtration uses a 0.8 μm filter to filter out impurities.

[0021] Preferably, in step 1: the dialysis purification uses a dialysis bag of 500-1000Da; the dialysis purification temperature is 30-37°C, and the dialysis time is 36-48h.

[0022] The molecular weight of toluidine blue is 656. Using a dialysis bag of 500-1000Da can maximize the dialysis efficiency. If the molecular weight cutoff of the dialysis bag is greater than 1000, it will affect the yield of the obtained platinum@toluidine blue carbon dot nanozyme. If the molecular weight cutoff of the dialysis bag is less than 500, while greatly reducing the dialysis efficiency, the impurities that have not reacted completely will also be retained in the dialysis bag, resulting in poor purification effect.

[0023] Preferably, in step 1: the rotation speed of the centrifugal washing is 6000-8000 rpm / min, the time is 15-20 min, the centrifugal temperature does not exceed 10° C., and the number of washing times is 3-5 times.

[0024] Preferably, in step 2: the molecular weight of the thiol-polyethylene glycol-amino group is 2000; the pH of the 2-morpholineethanesulfonic acid buffer is 5-6; and the concentration of the glucose oxidase solution is 1-2 mg / mL.

[0025] Preferably, in step 2: the centrifugal speed is 6000-8000 rpm / min, and the temperature is 8-10°C.

[0026] Preferably, in step 2: the rotation speed of the shaking incubation activation is 50-60 rpm / min, the incubation activation temperature is 30-37° C., and the incubation activation time is 30-40 min.

[0027] Preferably, in step 3: the pH of the phosphate buffered saline solution is 7-8; the temperature of the stirring and mixing is 30-37° C., and the time is 2-3 h.

[0028] Preferably, in step 4, the pH of the borate buffer solution is 8-8.5.

[0029] Preferably, in step 4, the shaking speed is 50-60 rpm / min, the incubation activation temperature is 30-37° C., and the incubation activation time is 30-40 min.

[0030] Preferably, in step 4, the dialysis purification uses a dialysis bag of 6000-8000Da; the dialysis purification temperature is 30-37°C, and the time is 36-48h.

[0031] Controlling the molecular weight cutoff of the dialysis bag within the above range can maximize the dialysis efficiency. If the molecular weight cutoff is too large or too small, the purity and yield of the obtained platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme will be reduced, affecting the therapeutic effect.

[0032] Preferably, in step 4, the molecular weight cutoff of the centrifugal ultrafiltration concentration is 8000-10000Da, the centrifugal speed is 6000-8000rpm / min, and the centrifugal time is 5-10min.

[0033] Controlling the molecular weight cutoff of ultrafiltration concentration within the above range can quickly and effectively increase the product concentration, while further removing small molecule impurities and ions in the solution, which would otherwise limit its ultimate therapeutic effect.

[0034] Compared with the prior art, the present invention has the following advantages:

[0035] The present invention firstly prepares platinum@toluidine blue carbon dot nanozyme by hydrothermal method, then synthesizes thiol-polyethylene glycol-glucose oxidase by thiol-polyethylene glycol-amino and glucose oxidase, then connects it through the coordination effect of thiol and platinum group, and finally coats platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme with folic acid, and finally obtains a tumor photodynamic therapy material with good biocompatibility and high singlet oxygen yield. The nanocomposite material obtained by the method can realize starvation / chemodynamic / photodynamic three-way synergistic therapy through multifunctionality, and realizes high singlet oxygen yield in tumor microenvironment through the cascade reaction effect of glucose oxidase and platinum@toluidine blue carbon dot nanozyme, which can enhance its anti-tumor effect and is expected to be actually used in tumor treatment. DETAILED DESCRIPTION

[0036] The technical content and effects of the present invention are further described in detail below in conjunction with the embodiments, but the present invention is not limited thereto.

[0037] Example 1

[0038] A method for preparing carbon dot nanozymes for strengthening hypoxic tumor photodynamic therapy by combining natural enzymes:

[0039] Step 1: Preparation of platinum-doped toluidine blue carbon dot nanozyme: 1.05g citric acid, 0.335mL ethylenediamine, 0.06g toluidine blue and 0.5179g chloroplatinic acid hexahydrate were added to 20mL deionized water while stirring, and then the solution was sealed in a 50mL hydrothermal reactor lined with Teflon and reacted at 180°C for 10h. After the reaction was completed and naturally cooled to room temperature, impurities were filtered out through a 0.8μm filter, and the product obtained after filtration was loaded into a dialysis bag with a molecular weight of 500Da, dialyzed and purified at 37°C for 48h in a 4L deionized water environment, and then centrifuged and washed 3 times with deionized water at 8000rpm / min, each time for 20min. Finally, the product after centrifugal washing was freeze-dried in a freeze dryer for 48h to obtain platinum@toluidine blue carbon dot nanozyme.

[0040] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: 20 mg of thiol-polyethylene glycol-amino solution with a molecular weight of 2000 was fully dissolved in 20 mL of 2-morpholineethanesulfonic acid buffer at pH = 5, 100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 60 mg of N-hydroxysuccinimide were added thereto, and after stirring for dissolution, the mixture was incubated for activation for 30 min at 37° C. on a shaking table with a rotation speed of 60 rpm / min. After the reaction was completed, 20 mL of a glucose oxidase solution with a concentration of 1 mg / mL was added, the pH value was adjusted to 7.0 with a borate buffer with a pH of 8.5, and then the mixture was incubated overnight at 37° C. on a shaking table with a rotation speed of 60 rpm / min. Subsequently, the obtained solution was centrifuged at 10° C., the precipitate was collected, and the mixture was diluted with deionized water to prepare a thiol-polyethylene glycol-glucose oxidase solution with a concentration of 2 mg / mL, which was refrigerated at 4° C. for use.

[0041] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 100 mg of platinum@toluidine blue carbon dot nanozyme in 50 mL of pH = 8 phosphate buffered saline solution, add 20 mL of 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, stir at 37 ° C for 2 h to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, and refrigerate at 4 ° C for use.

[0042] Step 4: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: 30 mg of folic acid was dissolved in 30 mL of borate buffer to prepare a folic acid solution, to which 20 mL of an aqueous solution containing 20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 12 mg of N-hydroxysuccinimide was added, and after stirring to dissolve, the mixture was placed in a shaker at 37°C with a rotation speed of 60 rpm / min and incubated for 30 min. After the reaction was completed, 30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution was added to the reaction system, incubated overnight at 37°C in a shaker with a rotation speed of 60 rpm / min, then placed in a dialysis bag with a molecular weight of 8000 Da, dialyzed and purified in a 4L deionized water environment at 37°C for 48 hours, and then concentrated by centrifugal ultrafiltration at 8000 rpm / min for 10 minutes with deionized water to obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0043] Comparative Example 1 (too low platinum doping amount)

[0044] Step 1: Preparation of platinum-doped toluidine blue carbon dot nanozyme: 1.05g citric acid, 0.335mL ethylenediamine, 0.06g toluidine blue and 0.4g chloroplatinic acid hexahydrate were added to 20mL deionized water while stirring, and then the solution was sealed in a 50mL hydrothermal reactor lined with Teflon and reacted at 180°C for 10h. After the reaction was completed and naturally cooled to room temperature, impurities were filtered out through a 0.8μm filter, and the product obtained after filtration was loaded into a dialysis bag with a molecular weight of 500Da, dialyzed and purified at 37°C for 48h in a 4L deionized water environment, and then centrifuged and washed 3 times with deionized water at 8000rpm / min, each time for 20min. Finally, the product after centrifugal washing was freeze-dried in a freeze dryer for 48h to obtain platinum@toluidine blue carbon dot nanozyme.

[0045] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: 20 mg of thiol-polyethylene glycol-amino solution with a molecular weight of 2000 was fully dissolved in 20 mL of 2-morpholineethanesulfonic acid buffer at pH = 5, 100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 60 mg of N-hydroxysuccinimide were added thereto, and after stirring for dissolution, the mixture was incubated for activation for 30 min at 37° C. on a shaking table with a rotation speed of 60 rpm / min. After the reaction was completed, 20 mL of a glucose oxidase solution with a concentration of 1 mg / mL was added, the pH value was adjusted to 7.0 with a borate buffer with a pH of 8.5, and then the mixture was incubated overnight at 37° C. on a shaking table with a rotation speed of 60 rpm / min. Subsequently, the obtained solution was centrifuged at 10° C., the precipitate was collected, and the mixture was diluted with deionized water to prepare a thiol-polyethylene glycol-glucose oxidase solution with a concentration of 2 mg / mL, which was refrigerated at 4° C. for use.

[0046] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 100 mg of platinum@toluidine blue carbon dot nanozyme in 50 mL of pH = 8 phosphate buffered saline solution, add 20 mL of 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, stir at 37 ° C for 2 h to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, and refrigerate at 4 ° C for use.

[0047] Step 4: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: 30 mg of folic acid was dissolved in 30 mL of borate buffer to prepare a folic acid solution, to which 20 mL of an aqueous solution containing 20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 12 mg of N-hydroxysuccinimide was added, and after stirring to dissolve, the mixture was placed in a shaker at 37°C with a rotation speed of 60 rpm / min and incubated for 30 min. After the reaction was completed, 30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution was added to the reaction system, incubated overnight at 37°C in a shaker with a rotation speed of 60 rpm / min, then placed in a dialysis bag with a molecular weight of 8000 Da, dialyzed and purified in a 4L deionized water environment at 37°C for 48 hours, and then concentrated by centrifugal ultrafiltration at 8000 rpm / min for 10 minutes with deionized water to obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0048] Comparative Example 2 (Too High Platinum Doping Amount)

[0049] Step 1: Preparation of platinum-doped toluidine blue carbon dot nanozyme: 1.05g citric acid, 0.335mL ethylenediamine, 0.06g toluidine blue and 0.7g chloroplatinic acid hexahydrate were added to 20mL deionized water while stirring, and then the solution was sealed in a 50mL hydrothermal reactor lined with Teflon and reacted at 180°C for 10h. After the reaction was completed and naturally cooled to room temperature, impurities were filtered out through a 0.8μm filter, and the product obtained after filtration was loaded into a dialysis bag with a molecular weight of 500Da, dialyzed and purified at 37°C for 48h in a 4L deionized water environment, and then centrifuged and washed 3 times with deionized water at 8000rpm / min, each time for 20min. Finally, the product after centrifugal washing was freeze-dried in a freeze dryer for 48h to obtain platinum@toluidine blue carbon dot nanozyme.

[0050] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: 20 mg of thiol-polyethylene glycol-amino solution with a molecular weight of 2000 was fully dissolved in 20 mL of 2-morpholineethanesulfonic acid buffer at pH = 5, 100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 60 mg of N-hydroxysuccinimide were added thereto, and after stirring for dissolution, the mixture was incubated for activation for 30 min at 37° C. on a shaking table with a rotation speed of 60 rpm / min. After the reaction was completed, 20 mL of a glucose oxidase solution with a concentration of 1 mg / mL was added, the pH value was adjusted to 7.0 with a borate buffer with a pH of 8.5, and then the mixture was incubated overnight at 37° C. on a shaking table with a rotation speed of 60 rpm / min. Subsequently, the obtained solution was centrifuged at 10° C., the precipitate was collected, and the mixture was diluted with deionized water to prepare a thiol-polyethylene glycol-glucose oxidase solution with a concentration of 2 mg / mL, which was refrigerated at 4° C. for use.

[0051] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 100 mg of platinum@toluidine blue carbon dot nanozyme in 50 mL of pH = 8 phosphate buffered saline solution, add 20 mL of 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, stir at 37 ° C for 2 h to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, and refrigerate at 4 ° C for use.

[0052] Step 4: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: 30 mg of folic acid was dissolved in 30 mL of borate buffer to prepare a folic acid solution, to which 20 mL of an aqueous solution containing 20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 12 mg of N-hydroxysuccinimide was added, and after stirring to dissolve, the mixture was placed in a shaker at 37°C with a rotation speed of 60 rpm / min and incubated for 30 min. After the reaction was completed, 30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution was added to the reaction system, incubated overnight at 37°C in a shaker with a rotation speed of 60 rpm / min, then placed in a dialysis bag with a molecular weight of 8000 Da, dialyzed and purified in a 4L deionized water environment at 37°C for 48 hours, and then concentrated by centrifugal ultrafiltration at 8000 rpm / min for 10 minutes with deionized water to obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0053] Comparative Example 3 (the amount of thiol-polyethylene glycol-amino group is too low)

[0054] Step 1: Preparation of platinum-doped toluidine blue carbon dot nanozyme: 1.05g citric acid, 0.335mL ethylenediamine, 0.06g toluidine blue and 0.5179g chloroplatinic acid hexahydrate were added to 20mL deionized water while stirring, and then the solution was sealed in a 50mL hydrothermal reactor lined with Teflon and reacted at 180°C for 10h. After the reaction was completed and naturally cooled to room temperature, impurities were filtered out through a 0.8μm filter, and the product obtained after filtration was loaded into a dialysis bag with a molecular weight of 500Da, dialyzed and purified at 37°C for 48h in a 4L deionized water environment, and then centrifuged and washed 3 times with deionized water at 8000rpm / min, each time for 20min. Finally, the product after centrifugal washing was freeze-dried in a freeze dryer for 48h to obtain platinum@toluidine blue carbon dot nanozyme.

[0055] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: 10 mg of thiol-polyethylene glycol-amino solution with a molecular weight of 2000 was fully dissolved in 20 mL of 2-morpholineethanesulfonic acid buffer at pH = 5, 100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 60 mg of N-hydroxysuccinimide were added thereto, and after stirring for dissolution, the mixture was incubated for activation for 30 min at 37° C. on a shaking table with a rotation speed of 60 rpm / min. After the reaction was completed, 20 mL of a glucose oxidase solution with a concentration of 1 mg / mL was added, the pH value was adjusted to 7.0 with a borate buffer with a pH of 8.5, and then the mixture was incubated overnight at 37° C. on a shaking table with a rotation speed of 60 rpm / min. Subsequently, the obtained solution was centrifuged at 10° C., the precipitate was collected, and the mixture was diluted with deionized water to prepare a thiol-polyethylene glycol-glucose oxidase solution with a concentration of 2 mg / mL, which was refrigerated at 4° C. for use.

[0056] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 100 mg of platinum@toluidine blue carbon dot nanozyme in 50 mL of pH = 8 phosphate buffered saline solution, add 20 mL of 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, stir at 37 ° C for 2 h to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, and refrigerate at 4 ° C for use.

[0057] Step 4: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: 30 mg of folic acid was dissolved in 30 mL of borate buffer to prepare a folic acid solution, to which 20 mL of an aqueous solution containing 20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 12 mg of N-hydroxysuccinimide was added, and after stirring to dissolve, the mixture was placed in a shaker at 37°C with a rotation speed of 60 rpm / min and incubated for 30 min. After the reaction was completed, 30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution was added to the reaction system, incubated overnight at 37°C in a shaker with a rotation speed of 60 rpm / min, then placed in a dialysis bag with a molecular weight of 8000 Da, dialyzed and purified in a 4L deionized water environment at 37°C for 48 hours, and then concentrated by centrifugal ultrafiltration at 8000 rpm / min for 10 minutes with deionized water to obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0058] Comparative Example 4 (Excessive dosage of thiol-polyethylene glycol-amino group)

[0059] Step 1: Preparation of platinum-doped toluidine blue carbon dot nanozyme: 1.05g citric acid, 0.335mL ethylenediamine, 0.06g toluidine blue and 0.5179g chloroplatinic acid hexahydrate were added to 20mL deionized water while stirring, and then the solution was sealed in a 50mL hydrothermal reactor lined with Teflon and reacted at 180°C for 10h. After the reaction was completed and naturally cooled to room temperature, impurities were filtered out through a 0.8μm filter, and the product obtained after filtration was loaded into a dialysis bag with a molecular weight of 500Da, dialyzed and purified at 37°C for 48h in a 4L deionized water environment, and then centrifuged and washed 3 times with deionized water at 8000rpm / min, each time for 20min. Finally, the product after centrifugal washing was freeze-dried in a freeze dryer for 48h to obtain platinum@toluidine blue carbon dot nanozyme.

[0060] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: 50 mg of thiol-polyethylene glycol-amino solution with a molecular weight of 2000 is fully dissolved in 20 mL of 2-morpholineethanesulfonic acid buffer at pH = 5, 100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 60 mg of N-hydroxysuccinimide are added thereto, and after stirring and dissolving, the mixture is incubated for activation for 30 min at 37° C. on a shaking table with a rotation speed of 60 rpm / min. After the reaction is completed, 20 mL of a glucose oxidase solution with a concentration of 1 mg / mL is added, the pH value is adjusted to 7.0 with a borate buffer with a pH of 8.5, and then the mixture is incubated overnight at 37° C. on a shaking table with a rotation speed of 60 rpm / min. Subsequently, the obtained solution is centrifuged at 10° C., the precipitate is collected, and the mixture is diluted with deionized water to prepare a thiol-polyethylene glycol-glucose oxidase solution with a concentration of 2 mg / mL, which is refrigerated at 4° C. for use.

[0061] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 100 mg of platinum@toluidine blue carbon dot nanozyme in 50 mL of pH = 8 phosphate buffered saline solution, add 20 mL of 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, stir at 37 ° C for 2 h to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, and refrigerate at 4 ° C for use.

[0062] Step 4: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: 30 mg of folic acid was dissolved in 30 mL of borate buffer to prepare a folic acid solution, to which 20 mL of an aqueous solution containing 20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 12 mg of N-hydroxysuccinimide was added, and after stirring to dissolve, the mixture was placed in a shaker at 37°C with a rotation speed of 60 rpm / min and incubated for 30 min. After the reaction was completed, 30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution was added to the reaction system, incubated overnight at 37°C in a shaker with a rotation speed of 60 rpm / min, then placed in a dialysis bag with a molecular weight of 8000 Da, dialyzed and purified in a 4L deionized water environment at 37°C for 48 hours, and then concentrated by centrifugal ultrafiltration at 8000 rpm / min for 10 minutes with deionized water to obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0063] Example 2

[0064] Step 1: Preparation of platinum-doped toluidine blue carbon dot nanozyme: 1.2 g citric acid, 0.4 mL ethylenediamine, 0.06 g toluidine blue and 0.6 g chloroplatinic acid hexahydrate were added to 30 mL deionized water while stirring, and then the solution was sealed in a 50 mL hydrothermal reactor lined with Teflon and reacted at 180 ° C for 10 h. After the reaction was completed and naturally cooled to room temperature, impurities were filtered out through a 0.8 μm filter, and the product obtained after filtration was loaded into a dialysis bag with a molecular weight of 500 Da, dialyzed and purified at 37 ° C for 48 h in a 4 L deionized water environment, and then centrifuged and washed 3 times with deionized water at 8000 rpm / min, each time for 20 min. Finally, the product after centrifugal washing was freeze-dried in a freeze dryer for 48 h to obtain platinum @ toluidine blue carbon dot nanozyme.

[0065] Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: 40 mg of thiol-polyethylene glycol-amino solution with a molecular weight of 2000 was fully dissolved in 20 mL of 2-morpholineethanesulfonic acid buffer at pH = 5, 100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 60 mg of N-hydroxysuccinimide were added thereto, and after stirring for dissolution, the mixture was incubated for activation for 30 min at 37° C. on a shaking table with a rotation speed of 60 rpm / min. After the reaction was completed, 10 mL of a 2 mg / mL glucose oxidase solution was added, the pH value was adjusted to 7.0 with a borate buffer at pH = 8.5, and then the mixture was incubated overnight at 37° C. on a shaking table with a rotation speed of 60 rpm / min. Subsequently, the obtained solution was centrifuged at 10° C., the precipitate was collected, and the mixture was diluted with deionized water to prepare a 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, which was refrigerated at 4° C. for use.

[0066] Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 80 mg of platinum@toluidine blue carbon dot nanozyme in 40 mL of pH = 8 phosphate buffered saline solution, add 20 mL of 2 mg / mL thiol-polyethylene glycol-glucose oxidase solution, stir at 37 ° C for 2 h to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, and refrigerate at 4 ° C for use.

[0067] Step 4: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: 30 mg of folic acid was dissolved in 20 mL of borate buffer to prepare a folic acid solution, to which 20 mL of an aqueous solution containing 20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 12 mg of N-hydroxysuccinimide was added, stirred to dissolve, and then placed in a shaker at 37°C with a rotation speed of 60 rpm / min for incubation and activation for 30 min. After the reaction was completed, 30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution was added to the reaction system, incubated overnight at 37°C in a shaker with a rotation speed of 60 rpm / min, then placed in a dialysis bag with a molecular weight of 8000 Da, dialyzed and purified in a 4L deionized water environment at 37°C for 48 hours, and then concentrated by centrifugal ultrafiltration at 8000 rpm / min for 10 minutes with deionized water to obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

[0068] Performance Testing

[0069] The prepared carbon dot nanozymes were added to the culture medium for cell culture experiments, and then the relative survival rate of the cells was determined by the MTT method. First, human cervical cancer (Hela) cells were cultured at 1×10 4The cells were inoculated at a density of 10 cells / well in a 96-well plate and incubated overnight in an incubator (37°C, 5% CO2). Then, 200 μL of a series of different concentrations (0, 5, 50, 100, 150, 200 μg / mL) of carbon dot nanozymes were cultured with the cells for 24 hours. The cells were treated with darkness and light for 5 min (660 nm 0.15 W / cm 2 ) treatment. Then, 20 μL of MTT solution was added to each well, incubated in an incubator for 4 hours, the culture medium was aspirated, 200 μL of DMSO solution was added to each well, and finally the absorbance of the solution in each well at a wavelength of 490 nm was measured by an enzyme-labeled instrument.

[0070] Table 1

[0071]

[0072] Table 2

[0073]

[0074]

[0075] As shown in Table 1, under dark conditions, the carbon dot nanozymes that were not treated with light showed lower toxicity to Hela cells, indicating that the material had good cell compatibility when not activated by light.

[0076] It can be seen from Table 2 that the carbon dot nanozymes treated with light clearly show strong killing power on Hela cells, and the cell viability is at a low level. By comparing the comparative examples 1-4 in the table, it can be found that after exceeding the dosage shown in the present invention, the cell viability is increased compared with Examples 1-2, that is, the tumor killing power is reduced, indicating that the dosage of the present invention has a certain preference, and under 660nm near-infrared light conditions, the survival rate of cancer cells decreases with the increase of the concentration of carbon dot nanozymes, indicating that the carbon dot nanozymes have high phototoxicity to cancer cells and have good catalase-like activity, decomposing hydrogen peroxide to generate oxygen, effectively improving the hypoxic environment of the tumor, and synergistic photosensitizer Ce6 can be effectively delivered to tumor tissue to achieve enhanced tumor-specific PDT effect.

[0077] The raw materials and equipment used in the present invention, unless otherwise specified, are all commonly used raw materials and equipment in the art; the methods used in the present invention, unless otherwise specified, are all conventional methods in the art.

[0078] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent transformation made to the above embodiment based on the technical essence of the present invention still falls within the protection scope of the technical solution of the present invention.

Claims

1. A method for preparing carbon dot nanozymes for enhancing photodynamic therapy of hypoxic tumors by combining natural enzymes, characterized in that The steps include: Step 1: Platinum @ toluidine blue carbon dot nanozyme: 1.0-1.2 g citric acid, 0.3-0.4 mL ethylenediamine, 0.06-0.08 g toluidine blue and 0.5-0.6 g chloroplatinic acid hexahydrate are added to 20-30 mL water under stirring, and the resulting solution is hydrothermally reacted at 160-180° C. for 10-12 h, cooled, filtered, and the filtrate is dialyzed for purification, centrifuged and washed, and freeze-dried to obtain platinum @ toluidine blue carbon dot nanozyme; Step 2: Preparation of thiol-polyethylene glycol-glucose oxidase: dissolve 20-40 mg of thiol-polyethylene glycol-amino in 10-20 mL of 2-morpholineethanesulfonic acid buffer, add 50-100 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 30-60 mg of N-hydroxysuccinimide, stir to dissolve, transfer to a shaker for incubation and activation, add 10-20 mL of glucose oxidase solution after completion, adjust the pH to 6.5-7.0, incubate on a shaker overnight, collect the precipitate by centrifugation, and dilute with water to obtain a 1-2 mg / mL thiol-polyethylene glycol-glucose oxidase solution; Step 3: Preparation of platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme: Disperse 80-100 mg of platinum@toluidine blue carbon dot nanozyme in 40-50 mL of phosphate buffered saline solution, add 10-20 mL of thiol-polyethylene glycol-glucose oxidase solution, stir and mix to obtain platinum@toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution; Step: 4: Preparation of platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme: dissolve 20-30 mg of folic acid in 20-30 mL of borate buffer to prepare a folic acid solution, add 10-20 mL of an aqueous solution containing 10-20 mg of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 6-12 mg of N-hydroxysuccinimide, stir to dissolve, transfer to a shaker for incubation and activation, and then add 20-30 mL of platinum @ toluidine blue-polyethylene glycol-glucose oxidase carbon dot nanozyme solution, incubate on a shaker overnight, dialysis purification, centrifugal ultrafiltration concentration, and obtain platinum @ toluidine blue-polyethylene glycol-glucose oxidase-folate carbon dot nanozyme.

2. The preparation method according to claim 1, characterized in that: In step 1: the filtration uses a 0.8 μm filter to filter out impurities.

3. The preparation method according to claim 1, characterized in that: In step 1: the dialysis purification uses a dialysis bag of 500-1000Da; the dialysis purification temperature is 30-37°C, and the dialysis time is 36-48h.

4. The preparation method according to claim 1, characterized in that: In step 1: the rotation speed of the centrifugal washing is 6000-8000 rpm / min, the time is 15-20 min, the centrifugal temperature does not exceed 10° C., and the number of washing times is 3-5 times.

5. The preparation method according to claim 1, characterized in that: In step 2: The molecular weight of the mercapto-polyethylene glycol-amino group is 2000; The pH of the 2-morpholineethanesulfonic acid buffer is 5-6; The concentration of the glucose oxidase solution is 1-2 mg / mL.

6. The preparation method according to claim 1, characterized in that: In step 2: the centrifugal speed is 6000-8000 rpm / min, and the temperature is 8-10°C.

7. The preparation method according to claim 1, characterized in that: In step 2: the rotation speed of the shaking incubation activation is 50-60 rpm / min, the incubation activation temperature is 30-37° C., and the incubation activation time is 30-40 min.

8. The preparation method according to claim 1, characterized in that: In step 3: the pH of the phosphate buffered saline solution is 7-8; the temperature of the stirring and mixing is 30-37° C., and the time is 2-3 hours.

9. The preparation method according to claim 1, characterized in that: In step 4, The pH of the borate buffer solution is 8-8.5; The shaking speed is 50-60 rpm / min, the incubation activation temperature is 30-37° C., and the incubation activation time is 30-40 min.

10. The preparation method according to claim 1, characterized in that: In step 4, The dialysis purification uses a 6000-8000Da dialysis bag; the dialysis purification temperature is 30-37°C and the time is 36-48h; The cut-off molecular weight of the centrifugal ultrafiltration concentration is 8000-10000Da, the centrifugal speed is 6000-8000rpm / min, and the centrifugal time is 5-10min.

Citation Information

Cited By

  • Fluorescent nano carbon dot for tumor photodynamic therapy based on ribosome affinity, preparation and application

    CN120204415A